Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Antares Pharma Inc (NASDAQ:ATRS)

0.9881
Delayed Data
As of 4:00pm ET
 -0.0919 / -8.51%
Today’s Change
0.88
Today|||52-Week Range
3.04
-18.34%
Year-to-Date
No recent news for Antares Pharma Inc.

Today’s Trading

Previous close1.08
Today’s open1.07
Day’s range0.96 - 1.07
Volume746,117
Average volume (3 months)967,113
Market cap$167.2M
Dividend yield--
Data as of 4:00pm ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)-68.75%
Earnings growth (this year)+51.85%
Earnings growth (next 5 years)+54.50%
Revenue growth (last year)+28.53%
P/E ratioNM
Price/Sales12.66
Price/Book3.45

Competitors

 Today’s
change
Today’s
% change
AVGRAvinger Inc+0.26+2.00%
IRMDIRadimed Corp+0.48+3.29%
UNISUnilife Corp-0.16-15.06%
SIENSientra Inc+1.36+15.81%
Data as of 4:00pm ET, 02/08/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$26.5M
Annual profit (last year)-$35.2M
Net profit margin-132.64%

Profile

Sector
Health Technology
Industry
Medical Specialties
President &
Chief Executive Officer
Robert F. Apple
Chief Financial Officer &
Senior Vice President
James E. Fickenscher
Corporate headquarters
Ewing, New Jersey

Forecasts

Partner Offers